Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study.

Rivera L, Sáez-Llorens X, Feris-Iglesias J, Ip M, Saha S, Adrian PV, Madhi SA, Boudville IC, Cunnington MC, Casellas JM, Slobod KS.

BMC Pediatr. 2015 Oct 1;15:143. doi: 10.1186/s12887-015-0460-2.

2.

Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group.

Levy Hara G, Gould I, Endimiani A, Pardo PR, Daikos G, Hsueh PR, Mehtar S, Petrikkos G, Casellas JM, Daciuk L, Paciel D, Novelli A, Saginur R, Pryluka D, Medina J, Savio E.

J Chemother. 2013 Jun;25(3):129-40. doi: 10.1179/1973947812Y.0000000062.

PMID:
23783137
3.

[Antibacterial drug resistance in Latin America: consequences for infectious disease control].

Casellas JM.

Rev Panam Salud Publica. 2011 Dec;30(6):519-28. Review. Spanish.

PMID:
22358396
4.

[Antimicrobial susceptibility testing in clinically relevant non-fermenting gram-negative bacilli: recommendations from the Antimicrobial Agents Subcommittee of the Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas, Asociación Argentina de Microbiología].

Radice M, Marín M, Giovanakis M, Vay C, Almuzara M, Limansky A, Casellas JM, Famiglietti A, Quinteros M, Bantar C, Galas M, Kovensky Pupko J, Nicola F, Pasterán F, Soloaga R, Gutkind G.

Rev Argent Microbiol. 2011 Apr-May;43(2):136-53. doi: 10.1590/S0325-75412011000200012. Spanish.

PMID:
21731977
5.

Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.

Tregnaghi MW, Abate HJ, Valencia A, Lopez P, Da Silveira TR, Rivera L, Rivera Medina DM, Saez-Llorens X, Gonzalez Ayala SE, De León T, Van Doorn LJ, Pilar Rubio MD, Suryakiran PV, Casellas JM, Ortega-Barria E, Smolenov IV, Han HH; Rota-024 Study Group.

Pediatr Infect Dis J. 2011 Jun;30(6):e103-8. doi: 10.1097/INF.0b013e3182138278.

PMID:
21378594
6.

Breastfeeding prevents severe disease in full term female infants with acute respiratory infection.

Libster R, Bugna Hortoneda J, Laham FR, Casellas JM, Israele V, Polack NR, Delgado MF, Klein MI, Polack FP.

Pediatr Infect Dis J. 2009 Feb;28(2):131-4. doi: 10.1097/INF.0b013e31818a8a82.

PMID:
19131900
7.

Prevalence of extended-spectrum beta-lactamases in South America.

Villegas MV, Kattan JN, Quinteros MG, Casellas JM.

Clin Microbiol Infect. 2008 Jan;14 Suppl 1:154-8. Erratum in: Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4.

8.

Comparative in vitro activity of tigecycline against aerobic and facultative isolates recovered from hospitalized patients: an Argentinean multicenter study.

Casellas JM, Bantar C, Duret F; Argentinean Collaborative Test Group.

J Chemother. 2007 Oct;19(5):482-7.

PMID:
18077902
9.

Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants.

Melendi GA, Laham FR, Monsalvo AC, Casellas JM, Israele V, Polack NR, Kleeberger SR, Polack FP.

Pediatrics. 2007 Aug;120(2):e410-5.

PMID:
17671045
10.

Biochemical characterization of PER-2 and genetic environment of blaPER-2.

Power P, Di Conza J, Rodríguez MM, Ghiglione B, Ayala JA, Casellas JM, Radice M, Gutkind G.

Antimicrob Agents Chemother. 2007 Jul;51(7):2359-65. Epub 2007 Apr 16.

11.

Review of pharmacokinetic, pharmacodynamic and clinical studies with a modern combination of amoxicillin/sulbactam.

Soutric J, Bantar C, Caruso N, Heguilén R, Casellas JM Jr, Casellas JM, Farinati A, Jasovich A, Arenoso H, Rodriguez M.

Chemotherapy. 2006;52(4):200-4. Epub 2006 May 24. Review.

PMID:
16720984
12.

Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children.

Casellas JM Jr, Israele V, Marín M, Ishida MT, Heguilen R, Soutric J, Arenoso H, Sibbald A, Stamboulian D.

Int J Pediatr Otorhinolaryngol. 2005 Sep;69(9):1225-33.

PMID:
16061111
13.

[Consensus for antimicrobial susceptibility testing for Enterobacteriaceae. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].

Famiglietti A, Quinteros M, Vázquez M, Marín M, Nicola F, Radice M, Galas M, Pasterán F, Bantar C, Casellas JM, Kovensky Pupko J, Couto E, Goldberg M, Lopardo H, Gutkind G, Soloaga R; Subcomisión de Antimicrobianos of the Sociedad Argentina de Bacteriología Clinica (Asociación Argentina de Microbiología).

Rev Argent Microbiol. 2005 Jan-Mar;37(1):57-66. Review. Spanish.

PMID:
15991480
14.

Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina.

Martin M, Casellas JM, Madhi SA, Urquhart TJ, Delport SD, Ferrero F, Chamany S, Dayan GH, Rose CE, Levine OS, Klugman KP, Feikin DR.

Pediatr Infect Dis J. 2004 Sep;23(9):842-7.

PMID:
15361724
15.

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.

Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL.

Clin Infect Dis. 2004 Jul 1;39(1):31-7. Epub 2004 Jun 8.

PMID:
15206050
16.

Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy.

Laham FR, Israele V, Casellas JM, Garcia AM, Lac Prugent CM, Hoffman SJ, Hauer D, Thumar B, Name MI, Pascual A, Taratutto N, Ishida MT, Balduzzi M, Maccarone M, Jackli S, Passarino R, Gaivironsky RA, Karron RA, Polack NR, Polack FP.

J Infect Dis. 2004 Jun 1;189(11):2047-56. Epub 2004 May 6.

PMID:
15143472
17.

CTX-M-12 beta-lactamase in a Klebsiella pneumoniae clinical isolate in Colombia.

Villegas MV, Correa A, Perez F, Zuluaga T, Radice M, Gutkind G, Casellas JM, Ayala J, Lolans K, Quinn JP; Colombian Nosocomial Resistance Study Group.

Antimicrob Agents Chemother. 2004 Feb;48(2):629-31.

18.

International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections.

Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL.

Ann Intern Med. 2004 Jan 6;140(1):26-32.

PMID:
14706969
19.

Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.

Casellas JM, Tomé G, Bantar C, Bertolini P, Blázquez N, Borda N, Couto E, Cudmani N, Guerrera J, Juárez MJ, López T, Littvik A, Méndez E, Notario R, Ponce G, Quinteros M, Salamone F, Sparo M, Sutich E, Vaylet S, Wolff L.

Diagn Microbiol Infect Dis. 2003 Nov;47(3):527-37.

PMID:
14596972
20.

Urine inhibitory titers against resistant Escherichia coli isolates after oral amoxicillin-sulbactam.

Casellas JM, Visser M, MacDougall N, Tomé G, Cohen HS, Soutric J, Arenoso H; South American Collaborative Group.

Medicina (B Aires). 2003;63(3):211-4.

PMID:
12876904
21.

[Consensus on antimicrobial sensitivity tests in gram-positive cocci. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].

Famiglietti A, Quinteros M, Predari SC, Corso A, Lopardo H, Casellas JM, Bantar C, Couto E, Galas M, Goldberg M, Gutkind G, Kovensky Pupko J, Marín M, Nicola F, Pasterán F, Radice M, Soloaga R.

Rev Argent Microbiol. 2003 Jan-Mar;35(1):29-40. Review. Spanish.

PMID:
12833678
22.

Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.

Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL.

Emerg Infect Dis. 2002 Feb;8(2):160-6.

23.

In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci.

Casellas JM, Tomé G, Visser M, Gliosca L.

Diagn Microbiol Infect Dis. 2002 Feb;42(2):107-12.

PMID:
11858905
24.

[Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections].

Casellas JM, Visser M, Mac Dougall N, Coco B, Tomé G, Gliosca L; Grupo Colaborativo de Telitromicina del Cono Sur.

Rev Esp Quimioter. 2001 Sep;14(3):269-74. Spanish.

PMID:
11753448
25.

[Escherichia coli eradication from the blader urine by amoxicillin-sulbactam. Intrinsic activity of the inhibitor].

Casellas JM, Visser M, Tomé G, Cohen H, Soutric J, Arenoso H.

Enferm Infecc Microbiol Clin. 2001 May;19(5):206-10. Spanish.

PMID:
11446908
26.

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice LB, McCormack JG, Yu VL.

J Clin Microbiol. 2001 Jun;39(6):2206-12. Review.

28.

Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening.

Guzmán-Blanco M, Casellas JM, Sader HS.

Infect Dis Clin North Am. 2000 Mar;14(1):67-81, viii. Review.

PMID:
10738673
29.

Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, Mohapatra S, Trenholme GM, Klugman KP, McCormack JG, Yu VL.

Clin Infect Dis. 2000 Mar;30(3):473-8.

PMID:
10722430
30.

Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.

Casellas JM, Gilardoni M, Tome G, Goldberg M, Ivanovic S, Orduna M, Dolmann A, Ascoli M, Ariza H, Montero JM.

J Antimicrob Chemother. 1999 Jun;43 Suppl C:37-42.

PMID:
10404336
31.

[Is sulbactam really the answer for treatment of infections caused by multiresistant strains of Acinetobacter spp.?].

Casellas JM, Dana R.

Enferm Infecc Microbiol Clin. 1997 Jun-Jul;15(6):335-6. Spanish. No abstract available.

PMID:
9376409
32.

Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase.

Bauernfeind A, Stemplinger I, Jungwirth R, Mangold P, Amann S, Akalin E, Anğ O, Bal C, Casellas JM.

Antimicrob Agents Chemother. 1996 Mar;40(3):616-20.

33.

Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases.

Bauernfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM.

Antimicrob Agents Chemother. 1996 Feb;40(2):509-13.

34.

Surgical-site infection due to Streptococcus pneumoniae following laparoscopic cholecystectomy.

Chá Torea JC, Rolón MJ, Grandjean M, Casellas JM.

Clin Infect Dis. 1994 Oct;19(4):803-4. No abstract available.

PMID:
7803663
35.

Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants.

Gonzalez Leiza M, Perez-Diaz JC, Ayala J, Casellas JM, Martinez-Beltran J, Bush K, Baquero F.

Antimicrob Agents Chemother. 1994 Sep;38(9):2150-7.

36.

The sleeping giant. Antimicrobial resistance.

Casellas JM, Blanco MG, Pinto ME.

Infect Dis Clin North Am. 1994 Mar;8(1):29-45. Review.

PMID:
8021447
37.

Serum and urinary cefpodoxime levels and time killing curves performed in the urine of children presenting urinary tract infections.

Casellas JM, Tome G, Exeni R, Grimoldi I, Goldberg M, Farinati AE.

Pathol Biol (Paris). 1993 Apr;41(4):385-91.

PMID:
8233640
38.

A new plasmidic cefotaximase from patients infected with Salmonella typhimurium.

Bauernfeind A, Casellas JM, Goldberg M, Holley M, Jungwirth R, Mangold P, Röhnisch T, Schweighart S, Wilhelm R.

Infection. 1992 May-Jun;20(3):158-63.

PMID:
1644493
39.

In vitro activity of cefpirome compared with other third generation cephalosporins against nosocomial isolates in Argentina.

Casellas JM, Goldberg M, Orellana N, Morosini MI, Negri MC, Arduino S.

Infection. 1990 May-Jun;18(3):193-5.

PMID:
2114372
40.

Incidence of strains producing extended spectrum beta-lactamases in Argentina.

Casellas JM, Goldberg M.

Infection. 1989 Nov-Dec;17(6):434-6.

PMID:
2613338
41.
42.

Cefotaxime therapy of urinary tract infections.

Casellas JM, Ortiz RG, Matteucci A, Iribarren MA, Farinati A.

J Antimicrob Chemother. 1980 Sep;6 Suppl A:225-30. No abstract available.

PMID:
6252161
43.

[Isolation of Vibrio parahemolyticus from mussel varieties in Argentina].

Casellas JM, Caría MA, Gerghi ME.

Rev Asoc Argent Microbiol. 1977 May-Aug;9(2):41-53. Spanish. No abstract available.

PMID:
594428
44.

Serum anti-Escherichia coli antibodies and urinary beta-glucuronidase for the diagnosis and control of evolution of urinary infection during pregnancy.

Vinacur JC, Casellas JM, Rubi RA, Oneto EP.

Am J Obstet Gynecol. 1974 Nov 15;120(6):812-6. No abstract available.

PMID:
4611215
45.

[New experiences with nalidixic acid in childhood urinary infections].

Taubenslag L, Casellas JM, Farinati A, Rybak A, Munich S, Troianovsky A.

Prensa Med Argent. 1971 Oct 22;58(34):1710-3. Spanish. No abstract available.

PMID:
5129858
46.

Gluconic acid forming bacteria from the soil: a new definition for the lwoffi-glucidolytica group of bacteria.

Casellas JM, Travassos LR.

An Microbiol (Rio J). 1968;15:81-5. No abstract available.

PMID:
5742778
47.

[Incidence of bacterial forms and of mycoplasmataceae in human pathology].

Rechniewski C, Casellas JM, Farinati A.

Prensa Med Argent. 1966;53(9):1279-83. Spanish. No abstract available.

PMID:
6004218

Supplemental Content

Loading ...
Support Center